Minjuvi

Indicated For

relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

About This Medication

# IncyteCARES for MONJUVI Patient Assistance Program Patient Guide: How to Get Minjuvi at Low or No Cost Minjuvi (tafasitamab-cxix) is a prescription medication used to treat certain types of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults after other treatments have failed. The **IncyteCARES for MONJUVI Patient Assistance Program (PAP)** from Incyte helps eligible **uninsured or underinsured patients** get Minjuvi free of charge, making this important therapy more accessible.[1][2][3] ## About Minjuvi and Why Assistance Matters **Minjuvi** is a targeted immunotherapy given as an intravenous (IV) infusion. It's FDA-approved for adults with relapsed or refractory DLBCL, including those who have received at least two prior therapies. DLBCL is an aggressive form of non-Hodgkin lymphoma, and Minjuvi works by binding to a protein on cancer cells called CD19, helping your immune system fight the lymphoma more effectively.[1] Treatment with Minjuvi can be expensive without help—often tens of thousands of dollars per cycle. The Patient Assistance Program covers the **cost of the medication itself** but does not cover infusion or administration fees, so check with your doctor's office or infusion center about those costs. This program is part of IncyteCARES for MONJUVI, a comprehensive support hub that also offers insurance navigation, education, and resources.[1][2] ## Who Qualifies for the Program? To join the **IncyteCARES for MONJUVI Patient Assistance Program**, you must first enroll in IncyteCARES for MONJUVI. Key requirements include: - Be a resident of the United States or Puerto Rico. - Have a **valid prescription** for Minjuvi for an FDA-approved use (e.g., relapsed or refractory DLBCL).[2] - Meet **uninsured or underinsured** criteria: - **Uninsured**: No medical coverage and meet household income criteria. - **Underinsured**: Exhausted coverage, denied coverage for Minjuvi, or on Medicare Part B without Medigap (but note: federal programs like Medicare, Medicaid, TRICARE may have separate rules).[2] - Enroll in IncyteCARES for MONJUVI first.[2] **Important note**: This PAP is separate from the IncyteCARES Savings Program, which is for patients with **commercial insurance** only (not uninsured, government insurance, or cash-pay). Always confirm your eligibility by calling.[2][5] ## Income Eligibility Breakdown The program requires meeting **household income criteria**, but specific Federal Poverty Level (FPL) percentages or dollar thresholds are not publicly detailed online. Eligibility is assessed case-by-case based on household size and income, typically for those at or below a certain FPL multiple (often 400-500% for similar programs, but verify with IncyteCARES). Provide proof of income during enrollment.[2] Here's a general table of what to expect (based on 2026 FPL guidelines; call for exact program thresholds): | Household Size | Example Income Threshold (e.g., up to 400% FPL)* | |----------------|-------------------------------------------------| | 1 person | ~$60,000 | | 2 people | ~$81,000 | | 3 people | ~$102,000 | | 4 people | ~$123,000 | | Add per person| ~$21,000 | *These are illustrative based on standard PAP structures; **actual thresholds vary**. Submit recent tax returns, pay stubs, or W-2s for verification. Program reps will review during enrollment.[2][4] ## Insurance Requirements - **Uninsured**: No insurance at all, plus income eligibility.[2] - **Underinsured**: Insurance denies or exhausts coverage for Minjuvi, or Medicare Part B without supplemental (Medigap). Provide proof of denial letter or exhaustion.[2] - **Not eligible**: Full coverage under government programs like Medicare Advantage, Medicaid, or TRICARE for the savings card—but PAP may still apply if underinsured for Minjuvi specifically.[2][5] IncyteCARES reps will review your coverage upon enrollment and guide you.[1] ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your oncologist for a valid Minjuvi prescription for FDA-approved use.[2] 2. **Enroll in IncyteCARES for MONJUVI**: Your doctor downloads the enrollment form from HCP.IncyteCARES.com/MONJUVI, completes it (about 15 minutes), and faxes to 1-866-870-6241. Include patient info, Medicare ID (if applicable), and optional financial details for PAP.[4] 3. **IncyteCARES Contact**: A rep calls you within **3 business days** to welcome you, verify insurance, assess PAP eligibility, and collect any missing info (e.g., income proof).[1][2][4] 4. **Submit Documents**: Provide: - Valid Minjuvi prescription. - Proof of income (tax return, pay stubs). - Proof of insurance status (denial letter, exhaustion notice, or uninsured confirmation).[2] 5. **Approval and Start**: If approved, medication ships free to your doctor's office. Program does **not** cover administration costs.[2][3] **Phone Support**: Call **(855) 452-5234** (Mon-Fri, 8 AM–8 PM ET) for help. Multiple application methods available (form, phone).[1][2] ## Timeline and Delivery - **Enrollment Contact**: Within 3 business days of faxed form.[4] - **Processing Time**: Not specified, but reps assist quickly; expect 1-2 weeks for full approval. - **Delivery**: Minjuvi ships **directly to your physician's office** for infusion. Your doctor coordinates scheduling.[2] - **Reauthorization**: **Required**—submit updated docs periodically to continue free supply.[2] ## Alternatives if Denied If you don't qualify: - IncyteCARES can refer you to **independent foundations** for copay, travel, or lodging help.[2] - Explore state programs, generic options (none currently), or clinical trials. - For commercial insurance: Switch to IncyteCARES Savings Program (covers out-of-pocket up to annual max).[2][5] - Contact general resources like NeedyMeds or PAN Foundation. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2024-2026. Program terms can change (last update May 1, 2024). **Eligibility, benefits, and availability are not guaranteed**. Does not cover infusion costs. Always call **(855) 452-5234** or visit IncyteCARES.com/MONJUVI for latest details, full terms, and personalized assessment. Consult your doctor for medical advice. IncyteCARES is not insurance.[1][2][5] (Word count: 1028)

Program information last verified: March 25, 2026